Posters/Exhibits/Break > Session
Posters/Exhibits/Break
Information
Coffee break sponsored by Spark Therapeutics, Inc.
Presentations
A1. ANTICOAGULATION CLINICS | |||||
|
(101) UNFRACTIONATED HEPARIN USE IN THE SETTING OF ACUTE PULMONARY EMBOLISM David Scott1, Zhongyuan Chen1, Aniko Szabo1, Lindsay Hammons1, Lisa Baumann Kreuziger1,2. 1Medical College of Wisconsin, Milwaukee, WI, USA 2Versiti Blood Center, Milwaukee, WI |
||||
A2. PLATELET ACTIVATION AND BIOCHEMISTRY | |||||
|
(102) IN VIVO VOLUME ELECTRON MICROSCOPY ANALYSIS AT THE SINGLE CELL LEVEL REVEALS REGIONAL INCREASES IN PLATELET SHAPE DISPERSITY ACROSS A MOUSE, JUGULAR VEIN PUNCTURE WOUND THROMBUS Madhavi A. Ariyarathne1, Irina D. Pokrovskaya1, Oliver S. Zhao2, Richard D. Leapman2, Maria A. Aronova2, Brian Storrie1. 1University of Arkansas for Medical Sciences, Little Rock, AR, USA 2National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, USA |
||||
A4. DISORDERS OF PLATELET NUMBER OR FUNCTION | |||||
|
(103) LONG-TERM EFFICACY AND SAFETY WITH ORAL BRUTON TYROSINE KINASE INHIBITOR RILZABRUTINIB IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA David J Kuter1, Terry Gernsheimer2, Waleed Ghanima3, Umer Khan4, Brad Ward5, Ahmed Daak5, Nichola Cooper6. 1Hematology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA 2University of Washington Medical Center, Seattle, WA, USA 3Østfold Hospital Foundation, Gralum, Norway 4Biostatistics, Sanofi, Bridgewater, NJ, USA 5Sanofi, Cambridge, MA, USA 6Department of Medicine, Hammersmith Hospital, London, United Kingdom |
||||
A5. BLOOD COAGULATION AND FIBRINOLYTIC FACTORS | |||||
|
(104) RISK FACTORS ASSOCIATED WITH VENOUS THROMBOEMBOLISM IN CHRONIC LYMPHOCYTIC LEUKEMIA Ambarina Faiz1, Shuang Guo1, Ashwin Sridharan1, Yong Lin2, 3, Claire Philipp1. 1Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA 2Rutgers School of Public Health, Piscataway, NJ, USA 3Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA |
||||
|
(105) OUTCOMES AND PREDICTORS OF IMMUNE THROMBOCYTOPENIA IN HOSPITALIZATIONS FOR ANTIPHOSPHOLIPID SYNDROME: A NATIONWIDE INPATIENT SAMPLE ANALYSIS Michael Imeh1, Ani Gvajaia1, Chukwunonye Amaeshi2, Fidelis Uwumiro3. 1Lincoln Medical and Mental Health Centre, Bronx, NY, USA 2Montefiore Medical Centre, Bronx, NY, USA 3University of Benin Teaching Hospital, Benin, Nigeria |
||||
|
(106) THE P.D1472H POLYMORPHISM IN THE VWF GENE IS COMMON IN INDIAN PATIENTS Ritika Sharma, Manu Jamwal, Harikishen Senee, Narender Kumar, Arihant Jain, Pankaj Malhotra, Deepak Bansal, Reena Das, Jasmina Ahluwalia. Postgraduate Institute of Medical Education and Research, Chandigarh, India |
||||
A6. DISORDERS OF COAGULATION OR FIBRINOLYSIS | |||||
|
(107) IRON DEFICIENCY HAS GENERALLY NOT BEEN CONSIDERED WHEN DEFINING SEX-BASED HEMOGLOBIN REFERENCE INTERVALS: A SYSTEMATIC REVIEW Ingrid Blydt-Hansen1, Vidushi Swarup2, Teruko Kishibe3, Carine Bekdache2, Vanessa Giuliano4, Rebecca Sampat2, Rowan Thillaye-Kerr2, Angela Weyand5, Mark Crowther6, Miranda Wozniak7, Grace H Tang8, Michelle Sholzberg8. 1Department of Internal Medicine, University of British Columbia, Vancouver, BC, Canada 2Hematology-Oncology Clinical Research Group, Division of Hematology-Oncology, St. Michael's Hospital, Toronto, Canada, Toronto, ON, Canada 3Health Sciences Library, St. Michael’s Hospital, Li Ka Shing Knowledge Institute, Toronto, ON, Canada 4Department of Medicine, University of Toronto, Toronto, ON, Canada 5Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA 6Department of Medicine, McMaster University, Hamilton, ON, Canada 7Department of Laboratory Medicine & Pathobiology, Hematological Pathology, University of Toronto,, Toronto, ON, Canada 8Departments of Medicine, and Laboratory Medicine and Pathobiology, St Michael’s Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, ON, Canada |
||||
|
(108) COAGULATION PROFILE AND CLOT STIFFNESS ANALYSIS FROM COVID-19-POSITIVE PATIENTS USING A NOVEL VISCOELASTICITY TESTING TECHNOLOGY Dimitria Bonizol Camasao1,2+, Jose G. Munguia-Lopez1+, Anna Perez5, José A. Correa3, Cedric Schmitt2, Anis Hadj Henni2, Chantal Séguin4, Donald C. Vinh5, Showan N. Nazhat1*. 1Department of Mining and Materials Engineering, McGill University, Montreal, QC, Canada 2Rheolution Inc., Montreal, QC, Canada 3Department of Mathematics and Statistics, McGill University, Montreal, QC, Canada 4Department of Medicine, Division of Hematology, McGill University Health Centre, McGill University, Montreal, QC, Canada 5Department of Experimental Medicine, Division of Infectious Diseases, McGill University Health Centre, McGill University, Montreal, QC, Canada |
||||
|
(109) IMPACT OF ANTICOAGULATION IN ACQUIRED HEMOPHILIA A Heather Frazier, Sean Dougherty, Kia Salafian, Hillary Maitland. University of Virginia, Charlottesville, VA, USA |
||||
|
(110) PRELIMINARY FINDINGS OF UTILIZING APTT ASSAY AS A SCREENING TOOL FOR LUPUS ANTICOAGULANT Suhhyun Kim, Daniel Sabath. Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA |
||||
|
(111) TIMELINESS OF HEMOSTATIC THERAPY ADMINISTRATION FOR PATIENTS WITH BLEEDING DISORDERS IN THE EMERGENCY DEPARTMENT Emily Kraft, Vanessa Bourck, Yuxin Zhang, Lisa Duffett, Alan Tinmouth, Tzu-Fei Wang, Roy Khalife. Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada |
||||
|
(112) EVALUATION OF REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH VON WILLEBRAND DISEASE TREATED PROPHYLACTICALLY WITH RECOMBINANT VON WILLEBRAND FACTOR ACROSS TREATMENT CENTERS IN THE UNITED STATES Jonathan C Roberts1, Maissaa Janbain2, Jessica R Marden3, Sanjana Sundaresan3, Natalia Nieto4, Bethany Jones4, Jorge Caicedo4. 1Bleeding & Clotting Disorders Institute, Peoria, IL, USA 2Tulane University School of Medicine, New Orleans, LA, USA 3Analysis Group, Inc., Boston, MA, USA 4Takeda Pharmaceuticals U.S.A., Inc, Lexington, MA, USA |
||||
|
(113) THE RELATIONSHIP BETWEEN DIFFERENT PAIN MEASURES, DEPRESSION, AND SOCIAL SUPPORT AND RACE AND ETHNICITY IN PERSONS WITH HEMOPHILIA. Maria E Santaella, Matthew Hartnett, Luke Luckey, Cynthia D Nichols. National Bleeding Disorders Foundation, New York, NY, USA |
||||
|
(114) BLEEDING DUET: A CASE OF SIMULTANEOUS ACQUIRED FACTOR VIII DEFICIENCY AND ACQUIRED VON WILLEBRAND SYNDROME Richard Yu1, Mathew Strelau1, Thunisa Shanmugalingham1 , Mackenzie Bowman2, Arnaud Bonnefoy3, Paula James2, Chai Phua1. 1University of Western Ontario, Department of Hematology, London, ON, Canada 2Queens University, Department of Hematology, Kingston, ON, Canada 3University of Montreal, Department of Hematology, Montreal, QC, Canada |
||||
A8. ANTITHROMBOTIC THERAPY | |||||
|
(115) THE IMPACT OF A HIGH-RISK ANTICOAGULATION PRESCRIBING STEWARDSHIP SCORING TOOL IMPLEMENTATION IN AN INPATIENT SETTING Emma Baker1, John Lindsley1, Ian Watt1, Rakhi Naik2, Michael Streiff2, Jennifer Yui2, Kathryn Dane1. 1The Johns Hopkins Hospital Department of Pharmacy, Baltimore, MD, USA 2Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA |
|||||
|
(116) DOES UNFRACTIONATED HEPARIN VERSUS LOW MOLECULAR WEIGHT HEPARIN FOR THROMBOPROPHYLAXIS REDUCE COMPLICATIONS NEAR DELIVERY? Sophia A. Cordes, Hani Faysal, Joaquin A. Calderon, Renxi Li, Sonya T. Gelfand, Mina Felfeli, Haeun Kim, Homa K. Ahmadzia. Department of Obstetrics and Gynecology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA |
||||
|
(117) RIVAROXABAN IN OLDER ADULTS WITH NONVALVULAR ATRIAL FIBRILLATION: POPULATION-BASED ANALYSIS IN RESPONSE TO UPDATED BEERS CRITERIA Ghadeer Dawwas1, Adam Cuker2. 1Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA 2Department of Medicine, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA |
||||
|
(118) MONITORING BIVALIRUDIN THERAPY USING A BIVALIRUDIN-SPECIFIC CHROMOGENIC ANTI-IIA ASSAY Sean G Yates1, Ravi Sarode1, Sarita Paulino1, Ibrahim F Ibrahim2, Lisa K Skariah3. 1Department of Pathology, Division of Transfusion Medicine and Hemostasis, University of Texas Southwestern Medical Center, Dallas, TX, USA 2Department of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA 3UT Southwestern Department of Pharmacy, University of Texas Southwestern Medical Center, Dallas, TX, USA |
||||
A9. INFORMATIONAL ABSTRACT (POSTER ONLY) | |||||
|
(119) INFLUENCE OF PHARMACEUTICAL INDUSTRY ON PUBLISHED CLINICAL TRIAL RESULTS Divyanka Kavdikar1, Siddharth Suresh1, Fakiha Siddiqui2, Atul Laddu1, Jawed Fareed2, Arav Raghunathan1, Ishvari Mokadam1. 1Global Thrombosis Forum, Suwanee, GA, USA 2Loyola University, Chicago, IL, USA |
||||
|
(120) CLINICAL EXPERIENCE USING REGIONAL CITRATE ANTICOAGULATION IN CONTINUOUS RENAL REPLACEMENT THERAPY IN A NEONATE WITH ACUTE KIDNEY FAILURE: CASE REPORT Jessica Santoyo Cueva1, Luis Ruben Miranda Ramirez1, Michelle Cecilia Arechiga Andrade1, Erendira Reyes Ramirez1. 1Instituto Pediacritica Hospital Puerta de Hierro Andares, Zapopan, Mexico 2Instituto Pediacritica Hospital Puerta de Hierro Andares, Zapopan, Mexico 3Instituto Pediacritica Hospital Puerta de Hierro Andares, Zapopan, Mexico 4Instituto Pediacritica Hospital Puerta de Hierro Andares, Zapopan, Mexico |
||||